Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

The prognostic impact of pathologic lymph nodes in HPV-positive oropharyngeal cancers.

El Asmar M, Tsai HL, Fakhry C, Maroun CA, Mandal R, Pardoll DM, Wang H.

Oral Oncol. 2019 Feb;89:23-29. doi: 10.1016/j.oraloncology.2018.12.005. Epub 2018 Dec 15.

PMID:
30732954
2.

Tobacco Treatment Programs at National Cancer Institute-designated Cancer Centers: A Systematic Review and Online Audit.

Day AT, Tang L, Karam-Hage M, Fakhry C.

Am J Clin Oncol. 2019 Feb 4. doi: 10.1097/COC.0000000000000522. [Epub ahead of print]

PMID:
30724778
3.

Sex differences in hpv immunity among adults without cancer.

Windon MJ, Waterboer T, Hillel AT, Chien W, Best S, Stewart C, Akst L, Troy T, Bender N, Miles B, Ryan WR, Mandal R, Pitman K, Eisele DW, Fakhry C, D'Souza G.

Hum Vaccin Immunother. 2019 Jan 16. doi: 10.1080/21645515.2019.1568157. [Epub ahead of print]

PMID:
30650013
4.

Priorities, concerns, and regret among patients with head and neck cancer.

Windon MJ, D'Souza G, Faraji F, Troy T, Koch WM, Gourin CG, Kiess AP, Pitman KT, Eisele DW, Fakhry C.

Cancer. 2019 Jan 15. doi: 10.1002/cncr.31920. [Epub ahead of print]

PMID:
30645761
5.

The Impact of a Stepwise Approach to Primary Tumor Detection in Squamous Cell Carcinoma of the Neck With Unknown Primary.

Ryan JF, Motz KM, Rooper LM, Mydlarz WK, Quon H, Gourin CG, Tan M, Eisele DW, Fakhry C.

Laryngoscope. 2018 Nov 22. doi: 10.1002/lary.27625. [Epub ahead of print]

PMID:
30565698
6.

The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.

Faraji F, Rettig EM, Tsai HL, El Asmar M, Fung N, Eisele DW, Fakhry C.

Cancer. 2019 Mar 1;125(5):761-769. doi: 10.1002/cncr.31841. Epub 2018 Dec 6.

PMID:
30521092
7.

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma.

Califano JA, Khan Z, Noonan KA, Rudraraju L, Zhang Z, Wang H, Goodman S, Gourin CG, Ha PK, Fakhry C, Saunders J, Levine M, Tang M, Neuner G, Richmon JD, Blanco R, Agrawal N, Koch WM, Marur S, Weed DT, Serafini P, Borrello I.

Clin Cancer Res. 2018 Dec 1;24(23):6100. doi: 10.1158/1078-0432.CCR-18-3298. No abstract available.

PMID:
30510089
8.

Association of Hospital Volume With Laryngectomy Outcomes in Patients With Larynx Cancer.

Gourin CG, Stewart CM, Frick KD, Fakhry C, Pitman KT, Eisele DW, Austin JM.

JAMA Otolaryngol Head Neck Surg. 2018 Nov 21. doi: 10.1001/jamaoto.2018.2986. [Epub ahead of print]

PMID:
30476965
9.

Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.

Eytan DF, Blackford AL, Eisele DW, Fakhry C.

Cancer. 2019 Jan 15;125(2):249-260. doi: 10.1002/cncr.31800. Epub 2018 Nov 16.

PMID:
30444527
10.

Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

Windon MJ, D'Souza G, Fakhry C.

Future Oncol. 2018 Oct;14(24):2521-2530. doi: 10.2217/fon-2018-0063. Epub 2018 Sep 28.

PMID:
30265132
11.

Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.

Eytan DF, Blackford AL, Eisele DW, Fakhry C.

Otolaryngol Head Neck Surg. 2019 Jan;160(1):85-92. doi: 10.1177/0194599818796163. Epub 2018 Sep 25.

PMID:
30252608
12.

In Regard to Bossi et al.

Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. No abstract available.

PMID:
30238902
13.

To kiss or not to kiss in the era of the human papillomavirus-associated head and neck cancer "epidemic"?

Rettig EM, Fakhry C, Nathan CO.

Laryngoscope. 2019 Jan;129(1):4-5. doi: 10.1002/lary.27277. Epub 2018 Sep 8. No abstract available.

PMID:
30194848
14.

Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement Summary of the CAP Guideline.

Fakhry C, Lacchetti C, Perez-Ordonez B.

J Oncol Pract. 2018 Oct;14(10):613-617. doi: 10.1200/JOP.18.00433. Epub 2018 Sep 7. No abstract available. Erratum in: J Oncol Pract. 2019 Jan;15(1):60.

PMID:
30192693
15.

Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline.

Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, Bell D, Lingen MW, Harichand-Herdt S, Thibo J, Zevallos J, Perez-Ordonez B.

J Clin Oncol. 2018 Nov 1;36(31):3152-3161. doi: 10.1200/JCO.18.00684. Epub 2018 Sep 6. Erratum in: J Clin Oncol. 2019 Jan 20;37(3):261.

PMID:
30188786
16.

Effects of a Comprehensive Performance Improvement Strategy on Postoperative Adverse Events in Head and Neck Surgery.

Panuganti B, Qiu Y, Messing B, Lee G, Fakhry C, Blanco R, Ha P, Messer K, Califano JA.

Otolaryngol Head Neck Surg. 2018 Aug 28:194599818793887. doi: 10.1177/0194599818793887. [Epub ahead of print]

PMID:
30149772
17.

Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.

Peng LC, Hui X, Cheng Z, Bowers MR, Moore J, Cecil E, Choflet A, Thompson A, Muse M, Kiess AP, Page BR, Gourin CG, Fakhry C, Szczesniak M, Maclean J, Wu P, Cook I, McNutt TR, Quon H.

Oral Oncol. 2018 Sep;84:25-30. doi: 10.1016/j.oraloncology.2018.05.012. Epub 2018 Jul 3.

PMID:
30115472
18.

Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.

Rettig EM, Zaidi M, Faraji F, Eisele DW, El Asmar M, Fung N, D'Souza G, Fakhry C.

Oral Oncol. 2018 Aug;83:147-153. doi: 10.1016/j.oraloncology.2018.06.013. Epub 2018 Jun 27.

PMID:
30098771
19.

HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.

Rettig EM, Bishop JA, Agrawal N, Chung CH, Sharma R, Zamuner F, Li RJ, Koch WM, Califano JA, Guo T, Gaykalova DA, Fakhry C.

Oral Oncol. 2018 Jul;82:168-175. doi: 10.1016/j.oraloncology.2018.05.017. Epub 2018 Jun 1.

PMID:
29909892
20.

P16 as a Prognostic Biomarker for Nonoropharyngeal Squamous Cell Cancers: Avatar or Mirage?

Fakhry C, Ferris RL.

J Natl Cancer Inst. 2018 Dec 1;110(12):1290-1291. doi: 10.1093/jnci/djy103. No abstract available.

PMID:
29878233
21.

Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.

Windon MJ, D'Souza G, Rettig EM, Westra WH, van Zante A, Wang SJ, Ryan WR, Mydlarz WK, Ha PK, Miles BA, Koch W, Gourin C, Eisele DW, Fakhry C.

Cancer. 2018 Jul 15;124(14):2993-2999. doi: 10.1002/cncr.31385. Epub 2018 Apr 30.

PMID:
29710393
22.

Age Profile of Patients With Oropharyngeal Squamous Cell Carcinoma.

Rettig EM, Fakhry C, Khararjian A, Westra WH.

JAMA Otolaryngol Head Neck Surg. 2018 Jun 1;144(6):538-539. doi: 10.1001/jamaoto.2018.0310. No abstract available.

PMID:
29710071
23.

Short- and long-term outcomes of oropharyngeal cancer care in the elderly.

Motz K, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Eisele DW, Koch WM, Frick KD, Gourin CG.

Laryngoscope. 2018 Sep;128(9):2084-2093. doi: 10.1002/lary.27153. Epub 2018 Mar 24.

PMID:
29573418
24.

Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy.

Rettig EM, Fakhry C, Hales RK, Kisuule F, Quon H, Kiess AP, Yin LX, Zhang Y, Blackford AL, Drummond MB, Gourin CG, Koch WM, Eisele DW, D'Souza G.

Head Neck. 2018 Jul;40(7):1534-1547. doi: 10.1002/hed.25148. Epub 2018 Mar 15.

PMID:
29542262
25.

Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.

Yin LX, D'Souza G, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig EM, Ryan WR, Ha PK, Wentz A, Koch W, Eisele DW, Fakhry C.

Laryngoscope. 2018 Aug;128(8):E287-E295. doi: 10.1002/lary.27130. Epub 2018 Mar 14.

PMID:
29536542
26.

Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals.

Fakhry C, Krapcho M, Eisele DW, D'Souza G.

Cancer. 2018 May 15;124(10):2125-2133. doi: 10.1002/cncr.31322. Epub 2018 Mar 13.

27.

Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research.

Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T.

Cancer. 2018 May 1;124(9):1859-1866. doi: 10.1002/cncr.31256. Epub 2018 Mar 2. No abstract available.

PMID:
29499070
28.

Evaluating oropharyngeal carcinoma with transcervical ultrasound, CT, and MRI.

Faraji F, Coquia SF, Wenderoth MB, Padilla ES, Blitz D, DeJong MR, Aygun N, Hamper UM, Fakhry C.

Oral Oncol. 2018 Mar;78:177-185. doi: 10.1016/j.oraloncology.2018.01.016. Epub 2018 Feb 20.

PMID:
29496048
29.

Bioinformatic Approach for Prediction of CsrA/RsmA-Regulating Small RNAs in Bacteria.

Fakhry CT, Zarringhalam K, Kulkarni RV.

Methods Mol Biol. 2018;1737:47-56. doi: 10.1007/978-1-4939-7634-8_3.

PMID:
29484586
30.

Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer.

Gipson BJ, Robbins HA, Fakhry C, D'Souza G.

Oral Oncol. 2018 Feb;77:52-56. doi: 10.1016/j.oraloncology.2017.12.008. Epub 2017 Dec 22.

31.

Reader performance in the ultrasonographic evaluation of oropharyngeal carcinoma.

Faraji F, Padilla ES, Blitz D, Wenderoth MB, Blanco RG, Kawamoto S, Sheth S, Hamper UM, Fakhry C.

Oral Oncol. 2018 Feb;77:105-110. doi: 10.1016/j.oraloncology.2017.12.012. Epub 2018 Jan 4.

PMID:
29362115
32.

Quality indicators of oropharyngeal cancer care in the elderly.

Gourin CG, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Koch WM, Eisele DW, Frick KD.

Laryngoscope. 2018 Oct;128(10):2312-2319. doi: 10.1002/lary.27050. Epub 2017 Dec 15.

PMID:
29243261
33.

Oral sampling methods are associated with differences in immune marker concentrations.

Fakhry C, Qeadan F, Gilman RH, Yori P, Kosek M, Patterson N, Eisele DW, Gourin CG, Chitguppi C, Marks M, Gravitt P.

Laryngoscope. 2018 Jun;128(6):E214-E221. doi: 10.1002/lary.27002. Epub 2017 Nov 24.

PMID:
29171655
34.

Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.

Quon H, Hui X, Cheng Z, Robertson S, Peng L, Bowers M, Moore J, Choflet A, Thompson A, Muse M, Kiess A, Page B, Fakhry C, Gourin C, O'Hare J, Graham P, Szczesniak M, Maclean J, Cook I, McNutt T.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1271-1278. doi: 10.1016/j.ijrobp.2017.08.004. Epub 2017 Aug 12.

PMID:
29165287
35.

Imbalance Between Clinical and Pathologic Staging in the Updated American Joint Commission on Cancer Staging System for Human Papillomavirus-Positive Oropharyngeal Cancer.

Fakhry C, Zevallos JP, Eisele DW.

J Clin Oncol. 2018 Jan 20;36(3):217-219. doi: 10.1200/JCO.2017.75.2063. Epub 2017 Nov 21. No abstract available.

PMID:
29161205
36.

Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.

D'Souza G, McNeel TS, Fakhry C.

Ann Oncol. 2017 Dec 1;28(12):3065-3069. doi: 10.1093/annonc/mdx535.

37.

Treatment, survival, and costs of oropharyngeal cancer care in the elderly.

Gourin CG, Fakhry C, Quon H, Kang H, Kiess AP, Herbert RJ, Eisele DW, Frick KD.

Laryngoscope. 2018 May;128(5):1103-1112. doi: 10.1002/lary.26887. Epub 2017 Oct 8.

PMID:
28988469
38.

Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers.

Rao AD, Coquia S, De Jong R, Gourin C, Page B, Latronico D, Dah S, Su L, Clarke S, Schultz J, Rosati LM, Fakhry C, Wong J, DeWeese TL, Quon H, Ding K, Kiess A.

Radiother Oncol. 2018 Jan;126(1):96-99. doi: 10.1016/j.radonc.2017.09.017. Epub 2017 Oct 3.

39.

Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.

Faraji F, Eisele DW, Fakhry C.

Laryngoscope Investig Otolaryngol. 2017 Jan 17;2(1):10-18. doi: 10.1002/lio2.37. eCollection 2017 Feb. Review.

40.

Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.

Gelwan E, Malm IJ, Khararjian A, Fakhry C, Bishop JA, Westra WH.

Am J Surg Pathol. 2017 Dec;41(12):1722-1728. doi: 10.1097/PAS.0000000000000929.

PMID:
28877058
41.

Prediction of bacterial small RNAs in the RsmA (CsrA) and ToxT pathways: a machine learning approach.

Fakhry CT, Kulkarni P, Chen P, Kulkarni R, Zarringhalam K.

BMC Genomics. 2017 Aug 22;18(1):645. doi: 10.1186/s12864-017-4057-z.

42.

The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.

Fung N, Faraji F, Kang H, Fakhry C.

Cancer Metastasis Rev. 2017 Sep;36(3):449-461. doi: 10.1007/s10555-017-9686-9. Review.

PMID:
28812214
43.

Utility of preoperative fine needle aspiration in parotid lesions.

Eytan DF, Yin LX, Maleki Z, Koch WM, Tufano RP, Eisele DW, Boahene KDO, Fakhry C, Bishop JA, Westra WH, Gourin CG.

Laryngoscope. 2018 Feb;128(2):398-402. doi: 10.1002/lary.26776. Epub 2017 Aug 7.

PMID:
28782105
44.

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML.

J Clin Oncol. 2017 Dec 20;35(36):4057-4065. doi: 10.1200/JCO.2016.72.0748. Epub 2017 Aug 4.

45.

Human papillomavirus tumour status is not associated with a positive depression screen for patients with oropharyngeal cancer.

Qualliotine JR, Califano JA, Li RJ, Gold D, Messing B, Lee G, Ha P, Fakhry C.

J Laryngol Otol. 2017 Sep;131(9):760-767. doi: 10.1017/S0022215117001098. Epub 2017 Jul 19.

PMID:
28720154
46.

Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.

Faraji F, Zaidi M, Fakhry C, Gaykalova DA.

Microbes Infect. 2017 Sep - Oct;19(9-10):464-475. doi: 10.1016/j.micinf.2017.06.001. Epub 2017 Jun 12. Review.

47.

Primary, secondary and tertiary prevention of human papillomavirus-driven head and neck cancers.

Mirghani H, Jung AC, Fakhry C.

Eur J Cancer. 2017 Jun;78:105-115. doi: 10.1016/j.ejca.2017.03.021. Epub 2017 Apr 20. Review.

PMID:
28437708
48.

Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.

Zhang Y, Waterboer T, Haddad RI, Miles BA, Wentz A, Gross ND, Fakhry C, Quon H, Lorch JH, Gourin CG, Clayburgh D, Misiukiewicz KJ, Richmon JD, Andersen PE, Posner MR, D'Souza G.

Oral Oncol. 2017 Apr;67:77-82. doi: 10.1016/j.oraloncology.2017.02.004. Epub 2017 Feb 15.

49.

AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus.

Guo T, Goldenberg D, Fakhry C.

Head Neck. 2017 May;39(5):833-839. doi: 10.1002/hed.24693. Epub 2017 Mar 6. Review.

PMID:
28263449
50.

The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.

Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, Koch W, Richmon JD, Eisele DW, D'Souza G.

Cancer. 2017 May 1;123(9):1566-1575. doi: 10.1002/cncr.30353. Epub 2017 Feb 27.

Supplemental Content

Loading ...
Support Center